| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V0238 | BI-D1870 | 501437-28-1 | BI-D1870 is a specific, cell permeable and ATP-competitive inhibitor of RSK1/2/3/4 (p90 ribosomal S6 kinase) with the potential to treatautoimmune encephalomyelitis (EAE). |
|
V0242 | LJI308 | 1627709-94-7 | LJI308 is a novel, potent, and pan-RSK (p90 ribosomal S6 kinase) inhibitor with potential antitumor activity. |
|
V0240 | LY2584702 | 1082949-67-4 | LY2584702 is a novel, selective, orally bioavailable, and ATP-competitive inhibitor of p70S6K (ribosomal p70 S6 kinase) with potential antitumor activity. |
|
V0241 | LY2584702 Tosylate (LYS-6K2) | 1082949-68-5 | LY2584702 Tosylate (also known as LYS6K2), the tosylate salt ofLY2584702,isa selective, orally bioavailable, and ATP-competitive p70S6K (ribosomal p70 S6 kinase) inhibitor with potential antitumor activity. |
|
V0239 | PF-4708671 | 1255517-76-0 | PF-4708671 is a novel, potent, highly specific and cell-permeable inhibitor of p70 ribosomal S6 kinase (S6K1 isoform)/RSK1 with potential antitumor activity. |